<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01004770</url>
  </required_header>
  <id_info>
    <org_study_id>GE-145-001</org_study_id>
    <nct_id>NCT01004770</nct_id>
  </id_info>
  <brief_title>Single Dose Safety, Tolerance and Pharmacokinetic Study in Healthy Volunteers Undergoing Contrast-enhanced Abdominal Computed Tomography (CT)</brief_title>
  <official_title>An Intravenous, Single Dose Safety, Tolerance and Pharmacokinetic Study of GE-145 in Healthy Volunteers Undergoing a Contrast-enhanced Abdominal Computed Tomography (CT) Scan</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>GE Healthcare</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medpace, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>i3 Statprobe</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>GE Healthcare</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a non-randomized dose-escalating study that will evaluate the safety and tolerability
      of GE-145 at four different dose levels through the assessment of clinical laboratories,
      vital signs, physical examinations, electrocardiograms (ECGs) and the frequency and intensity
      of adverse events (AEs). It will characterize the pharmacokinetic properties of GE-145
      through the evaluation of serum and urine. It will evaluate the radiographic density in
      regions of interest (ROI) and the overall diagnostic quality following administration of
      GE-145.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2009</start_date>
  <completion_date type="Actual">May 2010</completion_date>
  <primary_completion_date type="Actual">February 2010</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Blood Urea Nitrogen and Creatinine Serum Values</measure>
    <time_frame>Baseline and up to and including 72 hours post contrast administration</time_frame>
    <description>Blood Urea Nitrogen and Creatinine serum value results taken up to and including 72 hours.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Vital Signs (Blood Pressure) Systolic and Diastolic Values</measure>
    <time_frame>Baseline and up to and including 8 hours post contrast administation.</time_frame>
    <description>Systolic and Diastolic bolld pressure taken up to and including 8 hours</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Vital Sign (Heart Rate in Beats Per Minute-(Bpm)) Values</measure>
    <time_frame>Baseline and up to and including 8 hours post contrast administration</time_frame>
    <description>Heart Rate (beats per minute-(bpm)) taken up to and including 8 hours.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>12-Lead Electrocardiogram (ECG) Values</measure>
    <time_frame>Baseline and up to and including 24 hours post contrast administration</time_frame>
    <description>12-Lead ECG values taken up to and including 24 hours</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Radiographic Density of the Region of Interest (ROI) Between Pre and Post Contrast Image</measure>
    <time_frame>Pre and post contrast administration</time_frame>
    <description>Radiographic Density differences of the abdominal aorta, pre and post contrast on the Arterial Phase</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>1 (AH113111 Injection)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>2 (Visipaque Injection)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>An additional 10 subjects will receive Visipaque (iodixanol) 320 mg I/mL) at a dose of 450 mg/kg.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>GE-145 (AN113111) Injection</intervention_name>
    <description>40 healthy volunteers (10 per treatment group) will receive AH113111 320 mg I/mL at 1 of 4 possible doses (300, 450, 600, or 900 mg I/kg) as a single intravenous (IV) administration.</description>
    <arm_group_label>1 (AH113111 Injection)</arm_group_label>
    <other_name>AH113111</other_name>
    <other_name>GE-145</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Visipaque (iodixanol) Injection</intervention_name>
    <description>An additional 10 subjects will receive Visipaque (iodixanol) 320 mg I/mL) at a dose of 450 mg/kg.</description>
    <arm_group_label>2 (Visipaque Injection)</arm_group_label>
    <other_name>Visipaque</other_name>
    <other_name>Iodixanol</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy males and females between 18 and 60 years of age.

          -  For women who are either surgically sterile or are postmenopausal, enrollment in the
             study without a pregnancy test at screening will be allowed. For women of childbearing
             potential, the results of a serum and urine HCG pregnancy test (with the result known
             on the day of and before IMP administration) must be negative.

          -  Subjects are able and willing to comply with study procedures and sign an informed
             consent.

        Exclusion Criteria:

          -  Known history of a reaction to any iodinated-based contrast agent or with multiple
             allergies (i.e. foods, pets, medications, etc).

          -  Subjects receiving any medication for which the use of an iodinated contrast agent is
             contraindicated (i.e.. metformin).

          -  Subjects with suspicion or diagnosis of hyperthyroidism.

          -  Women that are breastfeeding at the screening and/or enrolment period.

          -  Usage of any non-FDA-approved pharmaceutical or therapy within 30 days prior to
             screening or enrolment in another clinical study within 30 days prior to screening.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rubin Sheng, MD</last_name>
    <role>Study Director</role>
    <affiliation>GE Healthcare</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>GE Healthcare</name>
      <address>
        <city>Princeton</city>
        <state>New Jersey</state>
        <zip>08540</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 23, 2009</study_first_submitted>
  <study_first_submitted_qc>October 29, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 30, 2009</study_first_posted>
  <results_first_submitted>September 14, 2011</results_first_submitted>
  <results_first_submitted_qc>March 7, 2012</results_first_submitted_qc>
  <results_first_posted type="Estimate">April 4, 2012</results_first_posted>
  <last_update_submitted>April 4, 2012</last_update_submitted>
  <last_update_submitted_qc>April 4, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 5, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>CECT - Contrast-enhanced computed tomography</keyword>
  <keyword>HCG - Human Chorionic Gonadotropin</keyword>
  <keyword>HU - Hounsfield Units</keyword>
  <keyword>Patient Safety</keyword>
  <keyword>Tolerance</keyword>
  <keyword>Pharmacokinetic</keyword>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>GE-145 Injection-300mg of Iodine/mL</title>
          <description>GE-145 x 300 milligram (mg) Iodine (I)/mL at doses of 300mgI/kg. The subjects in each dose group only received one dose.</description>
        </group>
        <group group_id="P2">
          <title>GE-145 Injection-450mg of Iodine/mL</title>
          <description>GE-145 x 450 milligram (mg) Iodine (I)/mL a doses of 450mgI/kg. The subjects in each dose group only received one dose.</description>
        </group>
        <group group_id="P3">
          <title>GE-145 Injection-600mg of Iodine/mL</title>
          <description>GE-145 x 600 milligram (mg) Iodine (I)/mL a doses of 600mgI/kg. The subjects in each dose group only received one dose.</description>
        </group>
        <group group_id="P4">
          <title>GE-145 Injection-900mg of Iodine/mL</title>
          <description>GE-145 x 900 milligram (mg) Iodine (I)/mL a doses of 900mgI/kg. The subjects in each dose group only received one dose.</description>
        </group>
        <group group_id="P5">
          <title>Visipaque Injection</title>
          <description>Visipaque x 320mgI/mL at a dose of 450mgI/kg</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="10"/>
                <participants group_id="P3" count="10"/>
                <participants group_id="P4" count="10"/>
                <participants group_id="P5" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="10"/>
                <participants group_id="P3" count="10"/>
                <participants group_id="P4" count="10"/>
                <participants group_id="P5" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>GE-145 Injection-300mg of Iodine/mL</title>
          <description>GE-145 x 300 milligram (mg) Iodine (I)/mL at doses of 300mgI/kg. The subjects in each dose group only received one dose.</description>
        </group>
        <group group_id="B2">
          <title>GE-145 Injection-450mg of Iodine/mL</title>
          <description>GE-145 x 450 milligram (mg) Iodine (I)/mL a doses of 450mgI/kg. The subjects in each dose group only received one dose.</description>
        </group>
        <group group_id="B3">
          <title>GE-145 Injection-600mg of Iodine/mL</title>
          <description>GE-145 x 600 milligram (mg) Iodine (I)/mL a doses of 600mgI/kg. The subjects in each dose group only received one dose.</description>
        </group>
        <group group_id="B4">
          <title>GE-145 Injection-900mg of Iodine/mL</title>
          <description>GE-145 x 900 milligram (mg) Iodine (I)/mL a doses of 900mgI/kg. The subjects in each dose group only received one dose.</description>
        </group>
        <group group_id="B5">
          <title>Visipaque Injection</title>
          <description>Visipaque x 320mgI/mL at a dose of 450mgI/kg</description>
        </group>
        <group group_id="B6">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="10"/>
            <count group_id="B2" value="10"/>
            <count group_id="B3" value="10"/>
            <count group_id="B4" value="10"/>
            <count group_id="B5" value="10"/>
            <count group_id="B6" value="50"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="10"/>
                    <measurement group_id="B4" value="10"/>
                    <measurement group_id="B5" value="10"/>
                    <measurement group_id="B6" value="50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26.5" spread="3.89"/>
                    <measurement group_id="B2" value="27.2" spread="11.54"/>
                    <measurement group_id="B3" value="30.8" spread="11.50"/>
                    <measurement group_id="B4" value="27.4" spread="10.05"/>
                    <measurement group_id="B5" value="31.3" spread="11.91"/>
                    <measurement group_id="B6" value="28.6" spread="10.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="9"/>
                    <measurement group_id="B4" value="3"/>
                    <measurement group_id="B5" value="2"/>
                    <measurement group_id="B6" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="7"/>
                    <measurement group_id="B5" value="8"/>
                    <measurement group_id="B6" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="10"/>
                    <measurement group_id="B4" value="10"/>
                    <measurement group_id="B5" value="10"/>
                    <measurement group_id="B6" value="50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Blood Urea Nitrogen and Creatinine Serum Values</title>
        <description>Blood Urea Nitrogen and Creatinine serum value results taken up to and including 72 hours.</description>
        <time_frame>Baseline and up to and including 72 hours post contrast administration</time_frame>
        <population>Per Study Protocol</population>
        <group_list>
          <group group_id="O1">
            <title>GE-145 Injection-300mg of Iodine/mL</title>
            <description>GE-145 x 300 milligram (mg) Iodine (I)/mL at doses of 300mgI/kg. The subjects in each dose group only received one dose.</description>
          </group>
          <group group_id="O2">
            <title>GE-145 Injection-450mg of Iodine/mL</title>
            <description>GE-145 x 450 milligram (mg) Iodine (I)/mL a doses of 450mgI/kg. The subjects in each dose group only received one dose.</description>
          </group>
          <group group_id="O3">
            <title>GE-145 Injection-600mg of Iodine/mL</title>
            <description>GE-145 x 600 milligram (mg) Iodine (I)/mL a doses of 600mgI/kg. The subjects in each dose group only received one dose.</description>
          </group>
          <group group_id="O4">
            <title>GE-145 Injection-900mg of Iodine/mL</title>
            <description>GE-145 x 900 milligram (mg) Iodine (I)/mL a doses of 900mgI/kg. The subjects in each dose group only received one dose.</description>
          </group>
          <group group_id="O5">
            <title>Visipaque Injection</title>
            <description>Visipaque x 320mgI/mL at a dose of 450mgI/kg</description>
          </group>
        </group_list>
        <measure>
          <title>Blood Urea Nitrogen and Creatinine Serum Values</title>
          <description>Blood Urea Nitrogen and Creatinine serum value results taken up to and including 72 hours.</description>
          <population>Per Study Protocol</population>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
                <count group_id="O3" value="10"/>
                <count group_id="O4" value="10"/>
                <count group_id="O5" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Blood Urea Nitrogen (BUN) - Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.3" spread="3.2"/>
                    <measurement group_id="O2" value="14.7" spread="3.0"/>
                    <measurement group_id="O3" value="14.5" spread="4.3"/>
                    <measurement group_id="O4" value="12.8" spread="4.5"/>
                    <measurement group_id="O5" value="11.9" spread="4.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>BUN - 8 h post</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.8" spread="3.1"/>
                    <measurement group_id="O2" value="14.2" spread="2.8"/>
                    <measurement group_id="O3" value="14.7" spread="6.5"/>
                    <measurement group_id="O4" value="11.8" spread="4.7"/>
                    <measurement group_id="O5" value="12.4" spread="2.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>BUN - 24 h post</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.1" spread="3.0"/>
                    <measurement group_id="O2" value="14.0" spread="2.9"/>
                    <measurement group_id="O3" value="12.5" spread="3.2"/>
                    <measurement group_id="O4" value="11.5" spread="3.3"/>
                    <measurement group_id="O5" value="11.2" spread="2.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>BUN - 48 h post</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.7" spread="3.1"/>
                    <measurement group_id="O2" value="14.8" spread="2.4"/>
                    <measurement group_id="O3" value="13.7" spread="4.7"/>
                    <measurement group_id="O4" value="12.4" spread="3.8"/>
                    <measurement group_id="O5" value="11.3" spread="3.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>BUN - 72 h post</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.2" spread="2.3"/>
                    <measurement group_id="O2" value="14.2" spread="2.8"/>
                    <measurement group_id="O3" value="14.9" spread="4.6"/>
                    <measurement group_id="O4" value="12.5" spread="3.7"/>
                    <measurement group_id="O5" value="12.5" spread="4.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Creatinine - Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.79" spread="0.19"/>
                    <measurement group_id="O2" value="0.79" spread="0.15"/>
                    <measurement group_id="O3" value="0.64" spread="0.10"/>
                    <measurement group_id="O4" value="0.87" spread="0.20"/>
                    <measurement group_id="O5" value="0.81" spread="0.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Creatinine - 8 h post</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.76" spread="0.19"/>
                    <measurement group_id="O2" value="0.82" spread="0.12"/>
                    <measurement group_id="O3" value="0.64" spread="0.11"/>
                    <measurement group_id="O4" value="0.83" spread="0.19"/>
                    <measurement group_id="O5" value="0.79" spread="0.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Creatinine - 24 h post</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.75" spread="0.19"/>
                    <measurement group_id="O2" value="0.78" spread="0.13"/>
                    <measurement group_id="O3" value="0.61" spread="0.10"/>
                    <measurement group_id="O4" value="0.76" spread="0.16"/>
                    <measurement group_id="O5" value="0.78" spread="0.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Creatinine - 48 h post</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.76" spread="0.21"/>
                    <measurement group_id="O2" value="0.78" spread="0.15"/>
                    <measurement group_id="O3" value="0.62" spread="0.11"/>
                    <measurement group_id="O4" value="0.88" spread="0.23"/>
                    <measurement group_id="O5" value="0.81" spread="0.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Creatinine - 72 h post</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.78" spread="0.15"/>
                    <measurement group_id="O2" value="0.74" spread="0.13"/>
                    <measurement group_id="O3" value="0.64" spread="0.13"/>
                    <measurement group_id="O4" value="0.82" spread="0.20"/>
                    <measurement group_id="O5" value="0.85" spread="0.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Vital Signs (Blood Pressure) Systolic and Diastolic Values</title>
        <description>Systolic and Diastolic bolld pressure taken up to and including 8 hours</description>
        <time_frame>Baseline and up to and including 8 hours post contrast administation.</time_frame>
        <population>Per Study Protocol</population>
        <group_list>
          <group group_id="O1">
            <title>GE-145 Injection-300mg of Iodine/mL</title>
            <description>GE-145 x 300 milligram (mg) Iodine (I)/mL at doses of 300mgI/kg. The subjects in each dose group only received one dose.</description>
          </group>
          <group group_id="O2">
            <title>GE-145 Injection-450mg of Iodine/mL</title>
            <description>GE-145 x 450 milligram (mg) Iodine (I)/mL a doses of 450mgI/kg. The subjects in each dose group only received one dose.</description>
          </group>
          <group group_id="O3">
            <title>GE-145 Injection-600mg of Iodine/mL</title>
            <description>GE-145 x 600 milligram (mg) Iodine (I)/mL a doses of 600mgI/kg. The subjects in each dose group only received one dose.</description>
          </group>
          <group group_id="O4">
            <title>GE-145 Injection-900mg of Iodine/mL</title>
            <description>GE-145 x 900 milligram (mg) Iodine (I)/mL a doses of 900mgI/kg. The subjects in each dose group only received one dose.</description>
          </group>
          <group group_id="O5">
            <title>Visipaque Injection</title>
            <description>Visipaque x 320mgI/mL at a dose of 450mgI/kg</description>
          </group>
        </group_list>
        <measure>
          <title>Vital Signs (Blood Pressure) Systolic and Diastolic Values</title>
          <description>Systolic and Diastolic bolld pressure taken up to and including 8 hours</description>
          <population>Per Study Protocol</population>
          <units>mm Hg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
                <count group_id="O3" value="10"/>
                <count group_id="O4" value="10"/>
                <count group_id="O5" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Systolic BP - Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="113.1" spread="10.87"/>
                    <measurement group_id="O2" value="125.5" spread="13.10"/>
                    <measurement group_id="O3" value="116.3" spread="11.49"/>
                    <measurement group_id="O4" value="114.9" spread="12.98"/>
                    <measurement group_id="O5" value="118.1" spread="12.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Systolic BP - 10 min post</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="110.6" spread="6.88"/>
                    <measurement group_id="O2" value="123.4" spread="8.32"/>
                    <measurement group_id="O3" value="115.3" spread="11.73"/>
                    <measurement group_id="O4" value="112.2" spread="13.31"/>
                    <measurement group_id="O5" value="118.0" spread="5.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Systolic BP - 20 min post</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="114.2" spread="8.51"/>
                    <measurement group_id="O2" value="121.8" spread="11.44"/>
                    <measurement group_id="O3" value="120.4" spread="5.78"/>
                    <measurement group_id="O4" value="112.6" spread="10.59"/>
                    <measurement group_id="O5" value="120.0" spread="4.99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Systolic BP - 1 h post</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="110.4" spread="9.65"/>
                    <measurement group_id="O2" value="120.5" spread="7.59"/>
                    <measurement group_id="O3" value="115.7" spread="11.13"/>
                    <measurement group_id="O4" value="112.7" spread="10.14"/>
                    <measurement group_id="O5" value="115.6" spread="9.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Systolic BP - 8 h post</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="113.6" spread="11.19"/>
                    <measurement group_id="O2" value="116.6" spread="16.60"/>
                    <measurement group_id="O3" value="99.0" spread="8.76"/>
                    <measurement group_id="O4" value="110.1" spread="10.69"/>
                    <measurement group_id="O5" value="115.3" spread="13.94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diastolic BP - Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="71.7" spread="9.32"/>
                    <measurement group_id="O2" value="72.5" spread="12.33"/>
                    <measurement group_id="O3" value="74.3" spread="9.03"/>
                    <measurement group_id="O4" value="69.9" spread="12.48"/>
                    <measurement group_id="O5" value="77.2" spread="9.52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diastolic BP - 10 min post</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="69.4" spread="9.65"/>
                    <measurement group_id="O2" value="74.3" spread="8.25"/>
                    <measurement group_id="O3" value="73.3" spread="10.52"/>
                    <measurement group_id="O4" value="70.4" spread="11.05"/>
                    <measurement group_id="O5" value="76.0" spread="9.83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diastolic BP - 20 min post</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="69.6" spread="8.47"/>
                    <measurement group_id="O2" value="70.8" spread="10.17"/>
                    <measurement group_id="O3" value="75.0" spread="7.06"/>
                    <measurement group_id="O4" value="71.8" spread="10.26"/>
                    <measurement group_id="O5" value="77.1" spread="7.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diastolic BP - 1 h post</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="67.4" spread="10.54"/>
                    <measurement group_id="O2" value="70.0" spread="5.79"/>
                    <measurement group_id="O3" value="70.4" spread="7.63"/>
                    <measurement group_id="O4" value="72.2" spread="7.50"/>
                    <measurement group_id="O5" value="72.2" spread="8.63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diastolic BP - 8 h post</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="70.4" spread="8.58"/>
                    <measurement group_id="O2" value="70.1" spread="10.96"/>
                    <measurement group_id="O3" value="64.5" spread="5.32"/>
                    <measurement group_id="O4" value="69.0" spread="5.60"/>
                    <measurement group_id="O5" value="68.8" spread="10.96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Vital Sign (Heart Rate in Beats Per Minute-(Bpm)) Values</title>
        <description>Heart Rate (beats per minute-(bpm)) taken up to and including 8 hours.</description>
        <time_frame>Baseline and up to and including 8 hours post contrast administration</time_frame>
        <population>Per Study Protocol</population>
        <group_list>
          <group group_id="O1">
            <title>GE-145 Injection-300mg of Iodine/mL</title>
            <description>GE-145 x 300 milligram (mg) Iodine (I)/mL at doses of 300mgI/kg. The subjects in each dose group only received one dose.</description>
          </group>
          <group group_id="O2">
            <title>GE-145 Injection-450mg of Iodine/mL</title>
            <description>GE-145 x 450 milligram (mg) Iodine (I)/mL a doses of 450mgI/kg. The subjects in each dose group only received one dose.</description>
          </group>
          <group group_id="O3">
            <title>GE-145 Injection-600mg of Iodine/mL</title>
            <description>GE-145 x 600 milligram (mg) Iodine (I)/mL a doses of 600mgI/kg. The subjects in each dose group only received one dose.</description>
          </group>
          <group group_id="O4">
            <title>GE-145 Injection-900mg of Iodine/mL</title>
            <description>GE-145 x 900 milligram (mg) Iodine (I)/mL a doses of 900mgI/kg. The subjects in each dose group only received one dose.</description>
          </group>
          <group group_id="O5">
            <title>Visipaque Injection</title>
            <description>Visipaque x 320mgI/mL at a dose of 450mgI/kg</description>
          </group>
        </group_list>
        <measure>
          <title>Vital Sign (Heart Rate in Beats Per Minute-(Bpm)) Values</title>
          <description>Heart Rate (beats per minute-(bpm)) taken up to and including 8 hours.</description>
          <population>Per Study Protocol</population>
          <units>&gt; 10 beats per minute (bpm)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
                <count group_id="O3" value="10"/>
                <count group_id="O4" value="10"/>
                <count group_id="O5" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Heart Rate - Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="65.8" spread="8.35"/>
                    <measurement group_id="O2" value="76.0" spread="11.53"/>
                    <measurement group_id="O3" value="77.9" spread="6.23"/>
                    <measurement group_id="O4" value="75.9" spread="15.00"/>
                    <measurement group_id="O5" value="86.1" spread="7.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Heart Rate - 10 min post</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="64.1" spread="9.78"/>
                    <measurement group_id="O2" value="75.7" spread="11.36"/>
                    <measurement group_id="O3" value="77.1" spread="10.38"/>
                    <measurement group_id="O4" value="78.6" spread="10.17"/>
                    <measurement group_id="O5" value="86.7" spread="8.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Heart Rate - 20 min post</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="65.0" spread="10.85"/>
                    <measurement group_id="O2" value="76.0" spread="12.41"/>
                    <measurement group_id="O3" value="75.4" spread="5.10"/>
                    <measurement group_id="O4" value="75.9" spread="9.70"/>
                    <measurement group_id="O5" value="87.4" spread="8.54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Heart Rate - 1 h post</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="65.1" spread="8.67"/>
                    <measurement group_id="O2" value="73.9" spread="8.60"/>
                    <measurement group_id="O3" value="72.5" spread="9.89"/>
                    <measurement group_id="O4" value="77.3" spread="9.87"/>
                    <measurement group_id="O5" value="78.5" spread="10.84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Heart Rate - 8 h post</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="69.1" spread="11.06"/>
                    <measurement group_id="O2" value="71.1" spread="15.89"/>
                    <measurement group_id="O3" value="75.2" spread="9.39"/>
                    <measurement group_id="O4" value="75.2" spread="12.04"/>
                    <measurement group_id="O5" value="79.4" spread="13.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>12-Lead Electrocardiogram (ECG) Values</title>
        <description>12-Lead ECG values taken up to and including 24 hours</description>
        <time_frame>Baseline and up to and including 24 hours post contrast administration</time_frame>
        <population>Per Study Protocol</population>
        <group_list>
          <group group_id="O1">
            <title>GE-145 Injection-300mg of Iodine/mL</title>
            <description>GE-145 x 300 milligram (mg) Iodine (I)/mL at doses of 300mgI/kg. The subjects in each dose group only received one dose.</description>
          </group>
          <group group_id="O2">
            <title>GE-145 Injection-450mg of Iodine/mL</title>
            <description>GE-145 x 450 milligram (mg) Iodine (I)/mL a doses of 450mgI/kg. The subjects in each dose group only received one dose.</description>
          </group>
          <group group_id="O3">
            <title>GE-145 Injection-600mg of Iodine/mL</title>
            <description>GE-145 x 600 milligram (mg) Iodine (I)/mL a doses of 600mgI/kg. The subjects in each dose group only received one dose.</description>
          </group>
          <group group_id="O4">
            <title>GE-145 Injection-900mg of Iodine/mL</title>
            <description>GE-145 x 900 milligram (mg) Iodine (I)/mL a doses of 900mgI/kg. The subjects in each dose group only received one dose.</description>
          </group>
          <group group_id="O5">
            <title>Visipaque Injection</title>
            <description>Visipaque x 320mgI/mL at a dose of 450mgI/kg</description>
          </group>
        </group_list>
        <measure>
          <title>12-Lead Electrocardiogram (ECG) Values</title>
          <description>12-Lead ECG values taken up to and including 24 hours</description>
          <population>Per Study Protocol</population>
          <units>QTcB (msec)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
                <count group_id="O3" value="10"/>
                <count group_id="O4" value="10"/>
                <count group_id="O5" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>ECG - Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="408.6" spread="24.3"/>
                    <measurement group_id="O2" value="420.2" spread="21.2"/>
                    <measurement group_id="O3" value="425.0" spread="17.9"/>
                    <measurement group_id="O4" value="410.2" spread="20.8"/>
                    <measurement group_id="O5" value="435.6" spread="17.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ECG - 20 min post</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="413.5" spread="18.4"/>
                    <measurement group_id="O2" value="422.9" spread="22.1"/>
                    <measurement group_id="O3" value="434.0" spread="14.2"/>
                    <measurement group_id="O4" value="418.2" spread="22.9"/>
                    <measurement group_id="O5" value="418.7" spread="24.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ECG - 24 h post</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="412.6" spread="15.4"/>
                    <measurement group_id="O2" value="411.4" spread="21.7"/>
                    <measurement group_id="O3" value="430.5" spread="18.8"/>
                    <measurement group_id="O4" value="401.5" spread="22.2"/>
                    <measurement group_id="O5" value="424.4" spread="19.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Radiographic Density of the Region of Interest (ROI) Between Pre and Post Contrast Image</title>
        <description>Radiographic Density differences of the abdominal aorta, pre and post contrast on the Arterial Phase</description>
        <time_frame>Pre and post contrast administration</time_frame>
        <population>Per Study Protocol</population>
        <group_list>
          <group group_id="O1">
            <title>GE-145 Injection-300mg of Iodine/mL</title>
            <description>GE-145 x 300 milligram (mg) Iodine (I)/mL at doses of 300mgI/kg. The subjects in each dose group only received one dose.</description>
          </group>
          <group group_id="O2">
            <title>GE-145 Injection-450mg of Iodine/mL</title>
            <description>GE-145 x 450 milligram (mg) Iodine (I)/mL a doses of 450mgI/kg. The subjects in each dose group only received one dose.</description>
          </group>
          <group group_id="O3">
            <title>GE-145 Injection-600mg of Iodine/mL</title>
            <description>GE-145 x 600 milligram (mg) Iodine (I)/mL a doses of 600mgI/kg. The subjects in each dose group only received one dose.</description>
          </group>
          <group group_id="O4">
            <title>GE-145 Injection-900mg of Iodine/mL</title>
            <description>GE-145 x 900 milligram (mg) Iodine (I)/mL a doses of 900mgI/kg. The subjects in each dose group only received one dose.</description>
          </group>
          <group group_id="O5">
            <title>Visipaque Injection</title>
            <description>Visipaque x 320mgI/mL at a dose of 450mgI/kg</description>
          </group>
        </group_list>
        <measure>
          <title>Radiographic Density of the Region of Interest (ROI) Between Pre and Post Contrast Image</title>
          <description>Radiographic Density differences of the abdominal aorta, pre and post contrast on the Arterial Phase</description>
          <population>Per Study Protocol</population>
          <units>Hounsfield Units</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
                <count group_id="O3" value="10"/>
                <count group_id="O4" value="10"/>
                <count group_id="O5" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Abdominal aorta-Pre-Contrast</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="39.8" spread="5.87"/>
                    <measurement group_id="O2" value="44.0" spread="5.83"/>
                    <measurement group_id="O3" value="44.7" spread="4.21"/>
                    <measurement group_id="O4" value="43.9" spread="3.56"/>
                    <measurement group_id="O5" value="44.5" spread="7.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Abdominal aorta-Post-Contrast</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="243.8" spread="41.78"/>
                    <measurement group_id="O2" value="263.6" spread="78.60"/>
                    <measurement group_id="O3" value="301.6" spread="74.96"/>
                    <measurement group_id="O4" value="305.8" spread="52.64"/>
                    <measurement group_id="O5" value="245.8" spread="45.69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>7 Day Followup</time_frame>
      <group_list>
        <group group_id="E1">
          <title>GE-145 Injection-300mg of Iodine/mL</title>
          <description>GE-145 x 300 milligram (mg) Iodine (I)/mL at doses of 300mgI/kg. The subjects in each dose group only received one dose.</description>
        </group>
        <group group_id="E2">
          <title>GE-145 Injection-450mg of Iodine/mL</title>
          <description>GE-145 x 450 milligram (mg) Iodine (I)/mL a doses of 450mgI/kg. The subjects in each dose group only received one dose.</description>
        </group>
        <group group_id="E3">
          <title>GE-145 Injection-600mg of Iodine/mL</title>
          <description>GE-145 x 600 milligram (mg) Iodine (I)/mL a doses of 600mgI/kg. The subjects in each dose group only received one dose.</description>
        </group>
        <group group_id="E4">
          <title>GE-145 Injection-900mg of Iodine/mL</title>
          <description>GE-145 x 900 milligram (mg) Iodine (I)/mL a doses of 900mgI/kg. The subjects in each dose group only received one dose.</description>
        </group>
        <group group_id="E5">
          <title>Visipaque Injection</title>
          <description>Visipaque x 320mgI/mL at a dose of 450mgI/kg</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA 10.1</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Radiation Exposure</sub_title>
                <description>Patient received radiation exposure</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA (10.1)</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Gastrointestinal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" events="3" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Skin</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Rubin Sheng, MD</name_or_title>
      <organization>GE Healthcare</organization>
      <phone>1-609-514-6899</phone>
      <email>rubin.sheng@ge.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

